Preparation of Nuflein - an Alkaloid from the Yellow Waterlily Nuphar Lutea - and its Cytotoxic Action on Cultures of Normal and Tumorous Human Cells
- Autores: Fedotcheva T.A.1,2, Sheichenko O.P.2, Anufrieva V.V.2, Sheichenko V.I.2, Fedotcheva N.I.3, Shimanovskii N.L.1
- 
							Afiliações: 
							- Science Research Laboratory of Molecular Pharmacology, N. I. Pirogov Russian National Medical Research University, Russian Ministry of Health
- All-Russian Institute of Medicinal and Aromatic Herbs
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
 
- Edição: Volume 51, Nº 7 (2017)
- Páginas: 590-595
- Seção: Medicinal Plants
- URL: https://ogarev-online.ru/0091-150X/article/view/244717
- DOI: https://doi.org/10.1007/s11094-017-1658-4
- ID: 244717
Citar
Resumo
The alkaloid from the yellow waterlily nuflein, whose preparation is described here, has cytotoxic activity against HeLa cervical cancer tumor cells. Suppression of the viability of normal fibroblasts requires nuflein concentrations 67 times greater than suppression of the viability of the same number of HeLa tumor cells. Cytotoxic activity is mediated by induction of the mitochondrial apoptosis pathway, as nuflein induces opening of mitochondrial pores and release of cytochrome c, which activates caspases. Nuflein also inhibits cellular energy generation due to uncoupling of oxidative phosphorylation in mitochondria and inhibition of mitochondrial respiration. The cytotoxic action of nuflein has been suggested to result from the properties of the sulfur atom in the thioether bond in the pharmacophore molecule. Utilization of the chemical properties of nuflein, allowing its steric structure to be “tuned,” may lead to the creation of a whole series of probes with different activities directed at modifying or inhibiting biologically important thiols. The greater selectivity of the antiproliferative activity of nuflein in relation to tumor cells as compared with the known antitumor substance cisplatin points to a specific antitumor nature for the activity of nuflein.
Palavras-chave
Sobre autores
T. Fedotcheva
Science Research Laboratory of Molecular Pharmacology, N. I. Pirogov Russian National Medical Research University, Russian Ministry of Health; All-Russian Institute of Medicinal and Aromatic Herbs
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow; Moscow						
O. Sheichenko
All-Russian Institute of Medicinal and Aromatic Herbs
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow						
V. Anufrieva
All-Russian Institute of Medicinal and Aromatic Herbs
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow						
V. Sheichenko
All-Russian Institute of Medicinal and Aromatic Herbs
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow						
N. Fedotcheva
Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Pushchino, Moscow District						
N. Shimanovskii
Science Research Laboratory of Molecular Pharmacology, N. I. Pirogov Russian National Medical Research University, Russian Ministry of Health
														Email: chem@folium.ru
				                					                																			                												                	Rússia, 							Moscow						
Arquivos suplementares
 
				
			 
						 
						 
						 
						 
					 
				 
  
  
  
  
  Enviar artigo por via de e-mail
			Enviar artigo por via de e-mail  Acesso aberto
		                                Acesso aberto Acesso está concedido
						Acesso está concedido Somente assinantes
		                                		                                        Somente assinantes
		                                					